It was detected that CCL19 was significantly and positively associated with inflammatory signaling pathways such as toll-like receptor 4 (TLR4)/NF-KB and proinflammatory factors, including IL-6 and TNF-α in NAFLD patients. This evidence concerns the gene CCL19 and metabolic dysfunction-associated steatotic liver disease.